Here is how many respondents considered each attribute “very important”:
1. Demonstrated clinical results: 64 percent
2. Controlling costs: 58 percent
3. Product quality: 52 percent
4. Improving patient satisfaction: 45 percent
5. Product is carried by my distributor: 9 percent
6. GPO Contract: 9 percent
7. Brand: 6 percent
Details on the survey and respondents can be found here.
More articles on benchmarking:
6 statistics on ASC acquisition activity, competition
7 regional statistics on ASC facility size
These are the top 6 benchmarks driving M&A strategies
